ADC Therapeutics SA Cash Flow Statement

ADCT $26.59 -1.9 -6.6%

26/02/21

Highly Speculative, Mid Cap, Sucker Stock

Market Cap £1.46bn

Enterprise Value £1.14bn

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock ADC Therapeutics SA's cashflow statement please upgrade your membership.

	2017	2018	2019
Period End:	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M
Currency:	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Other Assets
Accounts Payable
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.